Walgreens (NYSE: WAG) (Nasdaq: WAG) had May sales of $6.57 billion, an increase of 6.0 percent from $6.19 billion for the same month in fiscal 2013.
Total front-end sales increased 3.0 percent in May compared with the same month in fiscal 2013, while comparable store front-end sales increased 2.6 percent. Customer traffic in comparable stores decreased 0.5 percent while basket size increased 3.1 percent.
Prescriptions filled at comparable stores increased by 3.5 percent in May and increased 5.6 percent on a calendar day-shift adjusted basis. May 2014 had one additional Saturday and one fewer Wednesday compared with May 2013. These calendar shifts negatively impacted prescriptions filled at comparable stores by 2.1 percentage points.
May pharmacy sales increased by 7.9 percent. Comparable store pharmacy sales increased 5.5 percent and increased by a calendar day-shift adjusted 7.6 percent. Calendar day shifts negatively impacted pharmacy sales in comparable stores by 2.1 percentage points. Calendar day-shift adjusted comparable store pharmacy sales were negatively impacted by 1.3 percentage points due to generic drug introductions in the last 12 months. Pharmacy sales accounted for 64.2 percent of total sales for the month.Sales in comparable stores increased by 4.4 percent in May. Calendar day shifts negatively impacted total comparable sales by 1.3 percentage points. Generic drug introductions in the last 12 months negatively impacted total comparable sales by 0.8 percentage point. Total sales for the third quarter of fiscal 2014, which ended May 31, were $19.49 billion, up 6.5 percent from $18.65 billion in last year’s quarter. Comparable store sales for the third quarter of fiscal 2014 increased 5.1 percent, while front-end comparable store sales for the quarter increased 2.2 percent. Prescriptions filled at comparable stores increased 4.0 percent in the third quarter and comparable pharmacy sales increased 6.8 percent. Calendar 2014 year-to-date sales for the first five months were $31.90 billion, an increase of 5.5 percent from $30.24 billion in 2013.